Background Image
Table of Contents Table of Contents
Previous Page  52 / 66 Next Page
Information
Show Menu
Previous Page 52 / 66 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 32, No 3, May/June 2021

162

AFRICA

Raised blood pressure and cholesterol

In 2015 the percentage of men and women with raised blood

pressure (BP) [systolic BP (SBP) ≥ 140 mmHg or diastolic BP

(DBP) ≥ 90 mmHg] was 25.1 and 22.6%, respectively.

8

Country

data for raised total cholesterol level (≥ 5.0 mmol/l) in 2015 was

7.3% for men and 12.8% for women.

8

The percentage of DALYs

lost because of hypertension was 4.0%,

11

whereas mortality rate

caused by hypertensive heart disease was 1.7% in 2019,

7

which

was lower than the global figure of 2.05% (Table 1).

Physical activity

Inastudyamongadolescents,86.8%werefoundtobeinsufficiently

active [< 60 minutes of moderate to vigorous-intensity physical

activity (PA) daily].

12

In 2015, the age-standardised estimate

for adults who were insufficiently active (< 150 minutes of

moderate-intensity PA per week, or < 75 minutes of vigorous-

intensity PA per week) was 6.5%, which was much lower than

that of the global data at 27.5% (Table 1).

8

Overweight and obesity

In 2015, adults aged 18 to 69 years had a prevalence of overweight

[body mass index (BMI) ≥ 25–< 30 kg/m

2

] and obesity (BMI ≥

30 kg/m

2

) that was 19 and 8.9%, respectively.

8

More women were

respectively overweight or obese (24.9, 13.7%) than men (13.2,

4.3%) (Table 1).

8

Diabetes

The percentage of the population aged between 18 and 69

years old, defined with a fasting glucose of ≥ 7.0 mmol/l or on

medication for raised blood glucose (age-standardised) in 2015,

was 1.5% for men and 2.3% for women.

8

In 2019, the prevalence

of age-adjusted (adults 20–79 years) diabetes was 3.1%,

13

which is

lower than the global prevalence of 9.3% (Table 1).

13

Part C: Clinical practice and guidelines

Health system capacity and guidelines for NCD

risk factors

Kenya had an average of 1.6 physicians and 10 nurses per 10 000

of the population in 2018/19. The number of hospital beds

was 13.3 and reported as ‘The national average in-patient bed

density’ by the health facility assessment in 2018/19.

14

In 2018, a locally relevant clinical tool was developed to assess

CVD risk, which included locally relevant clinical guidelines for

CVD prevention and detecting and managing AF.

15

Guidelines

for managing pharyngitis were reported in 2009.

16

Locally

relevant clinical guidelines for the management of acute

rheumatic fever (ARF) and RHD have also been implemented,

as have those for the treatment of tobacco dependence and

its detection.

15

However, no clinical registers of people with a

history of ARF and RHD were available. In 2010, national

clinical guidelines for managing diabetes were developed based

on local and international best practices and updated in 2018.

17,18

Table 1. Cardiovascular disease indicators for Kenya

Indicators

Male

Female

Total

Year

Status of the national CVD epidemic

Premature CVD mortality (30–70 years old) (% deaths)

-

-

8

2012

Total CVD mortality (% of deaths)

12.9

15.0

13.8 (31.8)

7

2019

Total RHD mortality (% of deaths)

0.11

0.17

0.14 (.5)

7

2019

DALYs attributable to CVD (%)

6.5

6.04

6.29 (14.7)

7

2019

AF and atrial flutter (%)

0.1

0.07

0.09 (.5)

7

2019

Prevalence of RHD (%)

1.11

1.22

1.17 (.5)

7

2019

Tobacco and alcohol

Prevalence of adult tobacco use (≥ 15 years old) (%)

8

23 (36.1)

6

4.1 (6.8)

6

-

2015

Prevalence of youth (13–15-year-olds) tobacco use (%)

8

12.8 (18.4)

6

6.7 (8.3)

6

-

2013

Estimated direct (healthcare-related) cost of tobacco use in your population (current US$)

-

-

-

Proportion of premature CVD mortality attributable to tobacco (%)

-

-

2 (10)

7

2004

Recorded alcohol consumption per capita (≥ 15 years) (litres of pure alcohol) (three-year average)

1.7

2016-18

Raised blood pressure and cholesterol

Population (15–64 years old) with raised BP (SBP ≥ 140 mmHg or DBP ≥ 90 mmHg) (%)

8

25.1 (24.1)

6

22.6 (20.1)

6

-

2015

Population with raised TC (≥ 5.0 mmol/l) (%)

8

7.3

12.8

10.1 (38.9)

6

2015

DALYs attributable to hypertension (%)

4.05

3.95

4.0 (9.3)

7

2019

Mortality caused by hypertensive heart disease (% of deaths)

1.12

2.46

1.73 (2.05)

7

2019

Physical activity

Adolescents (11–17 years old) who are insufficiently active (< 60 minutes of moderate- to vigorous-

intensity PA daily) (%)

12

84.9

88.9

86.8 (80.7)

6

2015

Adults (age-standardised estimate) who are insufficiently active (< 150 minutes of moderate-intensity PA

per week, or < 75 minutes of vigorous-intensity PA per week) (%)

8

6.3

6.8

6.5 (27.5)

6

2015

Overweight and obesity

Adults (18−64 years old) who are overweight (BMI ≥ 25–< 30 kg/m

2

) (%)

8

13.2

24.9

19 (38.9)

6

2015

Prevalence of obesity (BMI ≥ 30 kg/m

2

) (adults 25−64 years old) (%)

8

4.3

13.7

8.9 (13.1)

6

2015

Diabetes

Defined population with fasting glucose ≥ 126 mg/dl (7.0 mmol/l) or on medication for raised blood

glucose (age-standardised) (%)

8

1.5 (9)

6

2.3 (8)

6

1.9

2015

Prevalence of diabetes (20−79 years old) (%)

-

-

3.1 (9.3)

13

2019

CVD, cardiovascular disease; RHD, rheumatic heart disease; DALYs, disability-adjusted life years; AF, atrial fibrillation; SBP, systolic blood pressure; DBP, diastolic

blood pressure; TC, total cholesterol; PA, physical activity; BMI, body mass index.

7

IHME global data exchange;

8

STEPS 2015;

6

WHO GHO data;

12

Guthold

et al

.;

13

IDF diabetes Atlas

.